Wide-complex tachycardia: Difference between revisions
No edit summary |
|||
| Line 27: | Line 27: | ||
==DDx Regular== | ==DDx Regular== | ||
#[[V Tach vs. SVT|V-Tach]] | #[[V Tach vs. SVT|V-Tach]] | ||
#SVT with aberrancy | |||
#Tachycardia + BBB | #Tachycardia + BBB | ||
#Tachycardia + rate related BBB | #Tachycardia + rate related BBB | ||
#Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig) | #Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig) | ||
#Pacemaker | #Pacemaker | ||
==DDX Irregular== | ==DDX Irregular== | ||
| Line 48: | Line 47: | ||
==See also== | ==See also== | ||
[[ACLS (2010 Guidelines)]] | *[[ACLS (2010 Guidelines)]] | ||
*[[V Tach vs. SVT]] | |||
[[V Tach vs. SVT]] | |||
==Source == | ==Source == | ||
Revision as of 20:52, 4 January 2012
Background
- Consider Hyperkalemia & Dig Toxicity
Diagnosis
Treatment
- Pulseless - Unsynchronized cardioversion 200J
- Unstable - shock (sync 100J -200J monophasic, or 50-100J biphasic)
- Stable
- Regular (tx as presumed V-tach)
- 1st Line
- Procainamide (20mg/min)
- Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
- Agent of choice in setting of AMI or LV dysfunction
- 2nd Line
- Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
- Torsades De Pointes
- Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
- Synchronized cardioversion (100 J)
- 1st Line
- Irregular (tx as presumed preexcited A-fib)
- Procainamide (20mg/min)
- Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
- Sotalol (100 mg IV over 5 minutes)
- Unsynchronized cardioversion (200J)
- Regular (tx as presumed V-tach)
DDx Regular
- V-Tach
- SVT with aberrancy
- Tachycardia + BBB
- Tachycardia + rate related BBB
- Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig)
- Pacemaker
DDX Irregular
- A-fib + BBB
- A-fib + rate related BBB
- QRS widest with shortest R-R
- Polymorphic v-tach/torsades
- A-fib + hyperkalemia or meds
- Accessory pathway
See also
Source
Rosen's
